NASDAQ:RCEL | Free Cash Flow | AVITA Medical, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-06-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$10.07M$19,000.00-$10.09M
2025-12-31-$5.44M-$674,000.00-$6.11M
2025-03-31-$10.31M$221,000.00-$10.53M
2024-12-31-$8.08M$1.61M-$9.69M
2024-03-31-$20.86M$1.15M-$22.01M
2023-12-31-$10.86M$296,000.00-$11.16M
2023-03-31-$9.07M$284,000.00-$9.36M
2022-12-31-$3.44M$70,000.00-$3.51M
2022-03-31-$9.37M$64,000.00-$9.43M
2021-09-30-$572,000.00$67,000.00-$639,000.00
2021-06-30-$3.95M$119,000.00-$4.07M
2021-03-31-$8.54M$326,000.00-$8.87M
2020-09-30-$7.71M$209,000.00-$7.92M
2020-06-30-$5.92M$126,000.00-$6.04M
2019-09-30-$4.88M$86,000.00-$4.97M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$31.2M$1.01M-$32.2M
2024-12-31-$48.94M$9.17M-$58.11M
2023-12-31-$38.01M$1.38M-$39.39M
2022-12-31-$19.09M$452,000.00-$19.54M
2021-06-30-$25.9M$894,000.00-$26.8M
2020-06-30-$22.75M$590,000.00-$23.34M
2019-06-30-$19.25M$1.02M-$20.27M
2018-06-30-$12.96M$365,000.00-$13.33M